Skip to main content

Together we are beating cancer

Donate now

Liver cancer

Showing 12 out of 34 results
A female nurse with a male patient

Three cancer drugs have been approved for patients on the NHS in Scotland, including a drug for some patients with advanced liver cancer. Three cancer drugs have been approved for patients on the NHS in Scotland, including a drug for some patients with advanced liver cancer.

by Cancer Research UK | News | 17 April 2019

17 April 2019

Researchers have launched a clinical trial to develop a breath test, analysing molecules that could indicate the presence of cancer at an early stage. Researchers have launched a clinical trial to develop a breath test, analysing molecules that could indicate the presence of cancer at an early stage.

by Cancer Research UK | News | 2 January 2019

2 January 2019

New trials results show that a drug can reduce hearing loss in children treated with the chemo drug cisplatin. New trials results show that a drug can reduce hearing loss in children treated with the chemo drug cisplatin.

by Katie Roberts | Analysis | 20 June 2018

20 June 2018

Earth

For this year’s World Cancer Day we're looking at how the rates of 4 types of cancer vary around the world, and why. For this year’s World Cancer Day we're looking at how the rates of 4 types of cancer vary around the world, and why.

by Emma Smith | Analysis | 4 February 2017

4 February 2017

Headlines suggested that jet lag could raise the risk of liver cancer. We spoke to an expert to find out the story. Headlines suggested that jet lag could raise the risk of liver cancer. We spoke to an expert to find out the story.

by Justine Alford | Analysis | 24 November 2016

24 November 2016

Luck
  • Science & Technology
  • Health & Medicine

Why cancer is (still) more than just ‘bad luck’

New research has uncovered a possible explanation for why some cancers are more common than others, we explore the details. New research has uncovered a possible explanation for why some cancers are more common than others, we explore the details.

by Emma Smith | Analysis | 25 August 2016

25 August 2016